Elamipretide is a cardiolipin peroxidase inhibitor and mitochondria-targeting peptide under the development of Stealth BioTherapeutics. It can Improve left Ventricular and Mitochondrial Function. Elamipretide can alleviate mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. It can prevent both iHTM and GTM(3) cells from sustained oxidative stress induced by H(2)O(2). Phase II clinical trials for the treatment of Chronic heart failure and Mitochondrial myopathies are ongoing.
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Elamipretide;736992-21-5;bendavia;SS-31 peptide;Arg-Dmt-Lys-Phe-NH2;SS31 peptide;MTP-131;D-Arg-Dmt-Lys-Phe-NH2;UNII-87GWG91S09;Ocuvia;Elamipretide [USAN:INN];MTP 131;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Szeto-schiller peptide;SS-31;Nh2-d-arg-dmt-lys-phe-nh2;MTP131;87GWG91S09;RX-31;(2S)-6-amino-2-[[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]hexanamide;(S)-6-amino-N-((S)-1-amino-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-((R)-2-amino-5-guanidinopentanamido)-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)hexanamide;Elamipretide [INN];Elamipretida;Elamipretide (USAN/INN);ELAMIPRETIDE [USAN];Elamipretide (MTP-131);ELAMIPRETIDE [WHO-DD];arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide;RX31;SS31;CHEMBL3833370;SCHEMBL15028020;DTXSID50471988;BDBM627985;D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide;D-Arg-Dmt-Lys-Phe-NH2;SS-31;EX-A7058;HY-P0125;MTP-131;MTP 131;MTP131;Bendavia;RX-31;(S)-6-amino-N-((S)-1-amino-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-((R)-2-amino-5-guanidinopentanamido)-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)hexanamide;s9803;AKOS027326652;CS-5846;DB11981;CVD-0019440;DA-63147;NS00072504;D10925;D78262;Q27269822; |
M.F/Formula | C32H49N9O5 |
M.W/Mr. | 639.8 |
Sequence | One Letter Code:RXKF Three Letter Code:H-D-Arg-Tyr(2,6-diMe)-Lys-Phe-NH2 |
Activity | Inhibitor |
Biological Activity | Elamipretide, also known as MTP-131 or D-Arg-Dmt-Lys-Phe-NH2,is a cardiolipin peroxidase inhibitor and mitochondria-targeted peptide. MTP-131 alleviates mitochondrial dysfunction and oxidative damage in human trabecular meshwork cells. MTP-131 could prevent both iHTM and GTM(3) cells from sustained oxidative stress induced by H(2)O(2). |
Target | Cardiolipin Peroxidase |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
InChI | InChI=1S/C32H49N9O5/c1-19-15-22(42)16-20(2)23(19)18-27(41-29(44)24(34)11-8-14-38-32(36)37)31(46)39-25(12-6-7-13-33)30(45)40-26(28(35)43)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-27,42H,6-8,11-14,17-18,33-34H2,1-2H3,(H2,35,43)(H,39,46)(H,40,45)(H,41,44)(H4,36,37,38)/t24-,25+,26+,27+/m1/s1 |
InChI Key | SFVLTCAESLKEHH-WKAQUBQDSA-N |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com